The use of adipokines and myokines measured in serum or cerebrospinal fluid as biomarkers or disease modifiers in neurological disorders is limited. Their permeability to the blood–brain barrier is either unknown or overlooked. A novel classification of adipokines and myokines on the basis of their cerebrospinal fluid to serum ratio is warranted.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout

References
Prodaniuc, A., Amalinei, C., Caruntu, I. D., Riscanu, A. L. & Grigoras, A. Parallel pathways, divergent outcomes: adipose tissue–neural crosstalk in depression and obesity. J. Clin. Med. 14, 8307 (2025).
Horváth, L. et al. Skeletal muscle as an auto-, para- and endocrine organ: the role of myokines in muscle metabolism and other metabolic organs. Physiol. Res. 74, S37–S56 (2025).
Huber, K., Szerenos, E., Lewandowski, D., Toczylowski, K. & Sulik, A. The role of adipokines in the pathologies of the central nervous system. Int. J. Mol. Sci. 24, 14684 (2023).
Miny, L. et al. Functional discrimination of CSF from Alzheimer’s patients in a brain on chip platform. Sci. Rep. 15, 29738 (2025).
Mineiro, R. et al. Melatonin and brain barriers: the protection conferred by melatonin to the blood-brain barrier and blood-cerebrospinal fluid barrier. Front. Neuroendocrinol. 75, 101158 (2024).
Heikamp, K., Hamers, T. & Hessel, E. V. S. In vitro human brain barrier models for studying thyroid hormone transport. Crit. Rev. Toxicol. 55, 645–661 (2025).
Morton, G. J., Cummings, D. E., Baskin, D. G., Barsh, G. S. & Schwartz, M. W. Central nervous system control of food intake and body weight. Nature 443, 289–295 (2006).
Bloemer, J. et al. Role of adiponectin in central nervous system disorders. Neural Plast. 2018, 4593530 (2018).
Neumeier, M. et al. Detection of adiponectin in cerebrospinal fluid in humans. Am. J. Physiol. Endocrinol. Metab. 293, E965–969 (2007).
Schmid, A. et al. Characterization of growth differentiation factor 15 (GDF15) as a neurotropic adipokine permeable to the brain. Sci. Rep. 15, 30138 (2025).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Supplementary information
Rights and permissions
About this article
Cite this article
Schäffler, A., Schmid, A. & Karrasch, T. Blood–brain barrier permeability of adipokines and myokines. Nat Rev Endocrinol (2026). https://doi.org/10.1038/s41574-026-01232-1
Published:
Version of record:
DOI: https://doi.org/10.1038/s41574-026-01232-1